Net delta exposure for CRISPR Therapeutics AG (CRSP) options was $36.15M per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $27.99M.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for CRSP, 2026-11-06(w), calls & puts
Delta Exposure Stats
Showing results for CRSP, 2026-11-06(w), calls & puts
Net Delta Exposure by Expiration
Showing results for CRSP, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
CRSP Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is CRSP delta exposure positive or negative?
CRISPR Therapeutics AG net delta exposure was positive on Nov 4, 2026, at $36.15M. It has been positive on 20 of the last 20 trading days.
How has CRSP delta exposure changed recently?
CRISPR Therapeutics AG net delta exposure went from $27.99M on Oct 7, 2026 to $36.15M on Nov 4, 2026. See the CRSP delta exposure history for a longer view.
What is CRISPR Therapeutics AG?
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics.